Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis

Post navigation

← Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature. 2006-2016

The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

Translation Disclaimer